PR Newswire
LEXINGTON, Mass., Sept. 19, 2017
LEXINGTON, Mass., Sept. 19, 2017 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immune-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that members of the Company's Leadership will present and host one-on-one meetings at two healthcare investment conferences in September. The details for the conferences are:
A live audio webcast will be available on the "Events & Presentations" section of the Company's investor website at www.agenusbio.com where a replay will also be available following the presentation.
About Agenus
Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing a number of combination approaches that leverage a broad repertoire of antibody therapeutics and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support early phase clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com; information that may be important to investors will be routinely posted on our website.
Contact:
Agenus Inc.
Jennifer Buell, PhD
781-674-4420
[email protected]
View original content with multimedia:http://www.prnewswire.com/news-releases/agenus-to-present-at-two-healthcare-investor-conferences-in-september-300521712.html
SOURCE Agenus Inc.
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member